SOFT
Jump to navigation
Jump to search
Addition of ovarian suppression to tamoxifen or exemestane reduced recurrence rates among women at increased risk for recurrence who received adjuvant chemotherapy.
Addition of ovarian suppression to tamoxifen or exemestane reduced recurrence rates among women at increased risk for recurrence who received adjuvant chemotherapy.